Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

INBX

Inhibrx Biosciences Inc

May 08 • 04:00PM ET

134.35

+9.83 7.89 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NRIX ARVN KYMR BCYC IDYA

| Held by: XBI IWM VTI IWN FYC IBB VXF FYX KOMP VFMO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-9.04	Insider Own	29.89%	Shs Outstand	14.58M	Perf Week	4.32%
Market Cap	1.96B	Forward P/E	-	EPS next Y	-5.61	Insider Trans	0.00%	Shs Float	10.24M	Perf Month	77.36%
Enterprise Value	1.95B	PEG	-	EPS next Q	-1.68	Inst Own	76.60%	Short Float	20.87%	Perf Quarter	60.11%
Income	-140.06M	P/S	1509.61	EPS this Y	13.38%	Inst Trans	29.34%	Short Ratio	6.63	Perf Half Y	63.30%
Sales	1.30M	P/B	245.03	EPS next Y	28.35%	ROA	-85.60%	Short Interest	2.14M	Perf YTD	70.06%
Book/sh	0.55	P/C	15.80	EPS next 5Y	26.70%	ROE	-197.85%	52W High	155.29 -13.48%	Perf Year	1093.16%
Cash/sh	8.50	P/FCF	-	EPS past 3/5Y	3.40% -	ROIC	-124.30%	52W Low	10.84 1139.39%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.98% -	Gross Margin	-91.00%	Volatility	10.51% 10.41%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1496.37	EPS Y/Y TTM	-107.76%	Oper. Margin	-10386.54%	ATR (14)	11.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.93	Sales Y/Y TTM	550.00%	Profit Margin	-10773.46%	RSI (14)	67.14	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	36.07%	SMA20	19.54%	Beta	3.83	Target Price	250.00
Payout	-	Debt/Eq	13.39	Sales Q/Q	-100.00%	SMA50	56.33%	Rel Volume	1.20	Prev Close	124.52
Employees	110	LT Debt/Eq	13.10	Earnings	Mar 19 AMC	SMA200	109.12%	Avg Volume	322.55K	Price	134.35
IPO	May 29, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.44% -	Trades		Volume	398,277	Change	7.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)